EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C41H64O14 |
| Net Charge | 0 |
| Average Mass | 780.949 |
| Monoisotopic Mass | 780.42961 |
| SMILES | [H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@@H](C5=CC(=O)OC5)CC[C@@]43O)[C@@]1(C)CC[C@H](O[C@H]1C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4C[C@H](O)[C@H](O)[C@@H](C)O4)[C@@H](C)O3)[C@@H](C)O1)C2 |
| InChI | InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1 |
| InChIKey | LTMHDMANZUZIPE-PUGKRICDSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Na+/K+-transporting ATPase (EC 3.6.3.9). epitope The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | cardiotonic drug A drug that has a strengthening effect on the heart or that can increase cardiac output. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. cardioprotective agent Any protective agent that is able to prevent damage to the heart. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| digoxin (CHEBI:4551) has role anti-arrhythmia drug (CHEBI:38070) |
| digoxin (CHEBI:4551) has role cardiotonic drug (CHEBI:38147) |
| digoxin (CHEBI:4551) has role EC 3.6.3.9 (Na+/K+-transporting ATPase) inhibitor (CHEBI:63510) |
| digoxin (CHEBI:4551) has role epitope (CHEBI:53000) |
| digoxin (CHEBI:4551) is a cardenolide glycoside (CHEBI:38092) |
| digoxin (CHEBI:4551) is a steroid saponin (CHEBI:61655) |
| digoxin (CHEBI:4551) is conjugate acid of digoxin(1−) (CHEBI:145795) |
| Incoming Relation(s) |
| 12-O-acetyldigoxin (CHEBI:71006) has functional parent digoxin (CHEBI:4551) |
| 20,22-dihydrodigoxin (CHEBI:71002) has functional parent digoxin (CHEBI:4551) |
| digoxin(1−) (CHEBI:145795) is conjugate base of digoxin (CHEBI:4551) |
| IUPAC Name |
|---|
| (3β,5β,12β)-3-{[2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide |
| INN | Source |
|---|---|
| digoxin | ChemIDplus |
| Synonym | Source |
|---|---|
| 12β-hydroxydigitoxin | ChemIDplus |
| Citations |
|---|